Business · Companies · 6 hrs ago
Kane Biotech accepts $250,000 interest-free loan from board chair
Winnipeg-based Kane Biotech accepted a $250,000 loan from Philip Renaud, the company’s board chair and an approved control person.
Kane Biotech develops and commercializes products and technologies aimed at microbial biofilms.
The loan is unsecured and carries no interest, and the company says it paid no bonus for it.
It is repayable on demand, so Renaud can require repayment.
Kane Biotech plans to use the money for working capital and corporate purposes.
The company intends to repay the loan using money from future fundraising or general revenue.
Kane Biotech Inc. accepted a $250,000 unsecured loan from board chair Philip Renaud.
The loan is interest-free and repayable on demand.
Renaud is also an approved control person of the company.
Kane Biotech plans to use the money for general working capital and corporate purposes.
The company intends to repay the loan from future capital raises or general revenue.
- Who
- Kane Biotech Inc. accepted the loan from Philip Renaud, its board chair and an approved control person.
- What
- The company accepted an unsecured, interest-free loan of $250,000, repayable on demand.
- When
- October 16, 2026.
- Where
- The announcement was issued from Winnipeg, Manitoba.
- Why
- The company plans to use the money for general working capital and corporate purposes.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Loan amount
- $250,000
- Lender
- Philip Renaud, board chair and approved control person
- Interest
- None
- Repayment
- On demand
- Company
- Kane Biotech Inc. (TSX-V:KNE)